QT
SWTX

Quantbot Technologies’s SpringWorks Therapeutics SWTX Stock Holding History

Quantbot Technologies’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-647
Closed -$23.4K – 1859
2024
Q4 		$23.4K Sell
647
-3,951
-86% -$138K ﹤0.01% 1352
2024
Q3 		$147K Buy
+4,598
New +$172K 0.01% 1091
2023
Q1 		– Sell
-16,700
Closed -$434K – 2047
2022
Q4 		$434K Buy
16,700
+11,200
+204% +$276K 0.03% 624
2022
Q3 		$156K Buy
+5,500
New +$158K 0.01% 961
2022
Q2 		– Sell
-308
Closed -$17K – 2116
2022
Q1 		$17K Sell
308
-1,292
-81% -$73.9K ﹤0.01% 1398
2021
Q4 		$99K Sell
1,600
-500
-24% -$33.1K 0.01% 875
2021
Q3 		$133K Buy
2,100
+1,100
+110% +$84.8K 0.01% 900
2021
Q2 		$82K Buy
+1,000
New +$75.9K 0.01% 967
2021
Q1 		– Sell
-100
Closed -$7K – 1746
2020
Q4 		$7K Buy
+100
New +$6.44K ﹤0.01% 1140

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Quantbot Technologies's SWTX Position: Q1 2025 in Review

Quantbot Technologies sold out of SpringWorks Therapeutics (SWTX) in Q1 2025, closing a stake of 647 shares — an estimated $23.4K sold.

Quantbot Technologies first reported a position in SWTX in Q4 2020 and held it in 9 quarters. The position peaked at $434K in Q4 2022. 306 funds tracked by Wall St. Rank hold SWTX as of Q1 2025.

  • Quantbot Technologies reported no remaining SpringWorks Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Quantbot Technologies sold 647 SpringWorks Therapeutics shares in Q1 2025, an estimated $23.4K.
  • Quantbot Technologies first reported a position in SpringWorks Therapeutics in Q4 2020 and held it in 9 quarters.
  • Quantbot Technologies's SpringWorks Therapeutics position peaked at $434K in Q4 2022.
  • 306 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q1 2025.

Based on Quantbot Technologies's 13F filing for Q1 2025, filed 13 May 2025.